Trial Outcomes & Findings for Investigating the Physiological Effects of Weight Loss on Male Fertility (NCT NCT03553927)

NCT ID: NCT03553927

Last Updated: 2024-11-07

Results Overview

The number of sperm per millimeter of semen. Sperm concentration is an important factor affecting male fertility. It is calculated on a standard semen analysis

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

73 participants

Primary outcome timeframe

16 weeks

Results posted on

2024-11-07

Participant Flow

Participant milestones

Participant milestones
Measure
Low Energy Diet
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Study A (Men With a Normal Sperm Conc.)
STARTED
14
14
Study A (Men With a Normal Sperm Conc.)
COMPLETED
12
12
Study A (Men With a Normal Sperm Conc.)
NOT COMPLETED
2
2
Study B (Men With a Low Sperm Conc.)
STARTED
22
23
Study B (Men With a Low Sperm Conc.)
COMPLETED
20
23
Study B (Men With a Low Sperm Conc.)
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Low Energy Diet
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Study A (Men With a Normal Sperm Conc.)
Withdrawal by Subject
2
2
Study B (Men With a Low Sperm Conc.)
Withdrawal by Subject
2
0

Baseline Characteristics

The overall number of baseline participants refers to the total number after combining the two sub-studies

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Low Energy Diet
n=32 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Total
n=67 Participants
Total of all reporting groups
Age, Categorical
Study A (men with a normal sperm concentration) · <=18 years
0 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Categorical
Study A (men with a normal sperm concentration) · Between 18 and 65 years
12 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
12 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
24 Participants
n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Categorical
Study A (men with a normal sperm concentration) · >=65 years
0 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Categorical
Study B (men with a low sperm concentration) · <=18 years
0 Participants
n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Categorical
Study B (men with a low sperm concentration) · Between 18 and 65 years
20 Participants
n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
23 Participants
n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
43 Participants
n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Categorical
Study B (men with a low sperm concentration) · >=65 years
0 Participants
n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
0 Participants
n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Continuous
Study A (men with a normal sperm concentration)
40.2 Years
STANDARD_DEVIATION 9.6 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
39.4 Years
STANDARD_DEVIATION 6.4 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
39.8 Years
STANDARD_DEVIATION 8 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Age, Continuous
Study B (men with a low sperm concentration)
37.7 Years
STANDARD_DEVIATION 6.6 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
39.5 Years
STANDARD_DEVIATION 7.5 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
38.6 Years
STANDARD_DEVIATION 7.1 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Sex: Female, Male
Female
0 Participants
n=32 Participants
0 Participants
n=35 Participants
0 Participants
n=67 Participants
Sex: Female, Male
Male
32 Participants
n=32 Participants
35 Participants
n=35 Participants
67 Participants
n=67 Participants
Race/Ethnicity, Customized
White
17 Participants
n=32 Participants
22 Participants
n=35 Participants
39 Participants
n=67 Participants
Race/Ethnicity, Customized
Mixed
0 Participants
n=32 Participants
2 Participants
n=35 Participants
2 Participants
n=67 Participants
Race/Ethnicity, Customized
Asian
7 Participants
n=32 Participants
9 Participants
n=35 Participants
16 Participants
n=67 Participants
Race/Ethnicity, Customized
Black
0 Participants
n=32 Participants
1 Participants
n=35 Participants
1 Participants
n=67 Participants
Race/Ethnicity, Customized
Arab
6 Participants
n=32 Participants
1 Participants
n=35 Participants
7 Participants
n=67 Participants
Race/Ethnicity, Customized
Other
2 Participants
n=32 Participants
0 Participants
n=35 Participants
2 Participants
n=67 Participants
Region of Enrollment
United Kingdom
32 participants
n=32 Participants
35 participants
n=35 Participants
67 participants
n=67 Participants
Weight
Study A (men with a normal sperm concentration)
109.5 Kilograms
STANDARD_DEVIATION 10.8 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
114.1 Kilograms
STANDARD_DEVIATION 11 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
112.6 Kilograms
STANDARD_DEVIATION 11.4 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Weight
Study B (men with a low sperm concentration)
116.8 Kilograms
STANDARD_DEVIATION 17.3 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
117 Kilograms
STANDARD_DEVIATION 21.9 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
116.9 Kilograms
STANDARD_DEVIATION 19.7 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Waist circumference
Study A (men with a normal sperm concentration)
117.3 Centimetres
STANDARD_DEVIATION 7.6 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
119.5 Centimetres
STANDARD_DEVIATION 9.1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
118.8 Centimetres
STANDARD_DEVIATION 8.4 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Waist circumference
Study B (men with a low sperm concentration)
123.4 Centimetres
STANDARD_DEVIATION 9.7 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
120.9 Centimetres
STANDARD_DEVIATION 12.9 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
122.1 Centimetres
STANDARD_DEVIATION 11.5 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Sperm concentration
Study A (men with a normal sperm concentration)
38.3 million sperms/mL
STANDARD_DEVIATION 15 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
54.2 million sperms/mL
STANDARD_DEVIATION 21.3 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
46.2 million sperms/mL
STANDARD_DEVIATION 19.8 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Sperm concentration
Study B (men with a low sperm concentration)
5.3 million sperms/mL
STANDARD_DEVIATION 3.4 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
9.8 million sperms/mL
STANDARD_DEVIATION 10.0 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
7.6 million sperms/mL
STANDARD_DEVIATION 7.9 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Semen volume
Study A (men with a normal sperm concentration)
3.3 ml
STANDARD_DEVIATION 1.4 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.9 ml
STANDARD_DEVIATION 1.1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.6 ml
STANDARD_DEVIATION 1.3 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Semen volume
Study B (men with a low sperm concentration)
3.7 ml
STANDARD_DEVIATION 1.8 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.3 ml
STANDARD_DEVIATION 1.4 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.4 ml
STANDARD_DEVIATION 1.6 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Progressive motility
Study A (men with a normal sperm concentration)
41 percentage of progressively motile sperm
STANDARD_DEVIATION 16 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
45 percentage of progressively motile sperm
STANDARD_DEVIATION 8 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
43 percentage of progressively motile sperm
STANDARD_DEVIATION 12 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
Progressive motility
Study B (men with a low sperm concentration)
28.7 percentage of progressively motile sperm
STANDARD_DEVIATION 13.2 • n=19 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
33.4 percentage of progressively motile sperm
STANDARD_DEVIATION 14.5 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
31.1 percentage of progressively motile sperm
STANDARD_DEVIATION 13.9 • n=39 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.
Total motility
Study A (men with a normal sperm concentration)
48 percentage of sperm that is motile
STANDARD_DEVIATION 17 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
52 percentage of sperm that is motile
STANDARD_DEVIATION 8 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
50 percentage of sperm that is motile
STANDARD_DEVIATION 13 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
Total motility
Study B (men with a low sperm concentration)
35 percentage of sperm that is motile
STANDARD_DEVIATION 13.8 • n=19 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
40 percentage of sperm that is motile
STANDARD_DEVIATION 15.5 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
36 percentage of sperm that is motile
STANDARD_DEVIATION 15 • n=39 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.
Body Mass Index (BMI)
Study A (men with a normal sperm concentration)
35.3 kg/m^2
STANDARD_DEVIATION 4.1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
36.2 kg/m^2
STANDARD_DEVIATION 2.4 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
35.8 kg/m^2
STANDARD_DEVIATION 3.3 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Body Mass Index (BMI)
Study B (men with a low sperm concentration)
38 kg/m^2
STANDARD_DEVIATION 4 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
38 kg/m^2
STANDARD_DEVIATION 6.3 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
38 kg/m^2
STANDARD_DEVIATION 5.3 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
DNA Fragmentation Index
Study A (men with a normal sperm concentration)
11.9 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 13.1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
15.9 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 6.7 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
13.8 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 9.5 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
DNA Fragmentation Index
Study B (men with a low sperm concentration)
15.8 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 7.7 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
12.1 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 9.5 • n=17 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
13.6 percentage of sperm with fragmented DNA
STANDARD_DEVIATION 8.9 • n=29 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA Fragmentation Index..
Testosterone
Study A (men with a normal sperm concentration)
12.7 nmol/l
STANDARD_DEVIATION 4.2 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
12.3 nmol/l
STANDARD_DEVIATION 2.5 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
12.5 nmol/l
STANDARD_DEVIATION 3.4 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Testosterone
Study B (men with a low sperm concentration)
12.6 nmol/l
STANDARD_DEVIATION 5.1 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
14.6 nmol/l
STANDARD_DEVIATION 5 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
13.4 nmol/l
STANDARD_DEVIATION 5.1 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Sex hormone-binding globulin (SHBG)
Study A (men with a normal sperm concentration)
21.8 nmol/l
STANDARD_DEVIATION 8.1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
25.2 nmol/l
STANDARD_DEVIATION 8.7 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
23.5 nmol/l
STANDARD_DEVIATION 8.4 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Sex hormone-binding globulin (SHBG)
Study B (men with a low sperm concentration)
21.4 nmol/l
STANDARD_DEVIATION 10.6 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
24.8 nmol/l
STANDARD_DEVIATION 9.6 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
23.2 nmol/l
STANDARD_DEVIATION 10.1 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Reactive oxygen species (ROS)
Study B (men with a low sperm concentration)
8.6 RLU/sec/million sperm
n=13 Participants • ROS was only measured in Study B. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure ROS. .
3.6 RLU/sec/million sperm
n=17 Participants • ROS was only measured in Study B. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure ROS. .
7.1 RLU/sec/million sperm
n=30 Participants • ROS was only measured in Study B. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure ROS. .
Morphology
Study A (men with a normal sperm concentration)
1.6 percentage of sperm of normal morphology
STANDARD_DEVIATION 1.3 • n=12 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
1.8 percentage of sperm of normal morphology
STANDARD_DEVIATION 1.4 • n=12 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
1.7 percentage of sperm of normal morphology
STANDARD_DEVIATION 1.3 • n=24 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
Morphology
Study B (men with a low sperm concentration)
0.4 percentage of sperm of normal morphology
STANDARD_DEVIATION 0.7 • n=17 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
1 percentage of sperm of normal morphology
STANDARD_DEVIATION 0.8 • n=20 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
0.7 percentage of sperm of normal morphology
STANDARD_DEVIATION 0.8 • n=37 Participants • Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to analyze morphology.
Luteinizing Hormone (LH)
Study A (men with a normal sperm concentration)
3.2 IU/l
STANDARD_DEVIATION 1 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.5 IU/l
STANDARD_DEVIATION 1.7 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
3.3 IU/l
STANDARD_DEVIATION 1.4 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Luteinizing Hormone (LH)
Study B (men with a low sperm concentration)
3.7 IU/l
STANDARD_DEVIATION 0.9 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
4.3 IU/l
STANDARD_DEVIATION 1.5 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
4 IU/l
STANDARD_DEVIATION 1.2 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Follicle Stimulating Hormone (FSH)
Study A (men with a normal sperm concentration)
4.2 IU/l
STANDARD_DEVIATION 2.6 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
4.4 IU/l
STANDARD_DEVIATION 1.9 • n=12 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
4.3 IU/l
STANDARD_DEVIATION 2.8 • n=24 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
Follicle Stimulating Hormone (FSH)
Study B (men with a low sperm concentration)
5.6 IU/l
STANDARD_DEVIATION 2.9 • n=20 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
5 IU/l
STANDARD_DEVIATION 2.5 • n=23 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies
5.3 IU/l
STANDARD_DEVIATION 2.7 • n=43 Participants • The overall number of baseline participants refers to the total number after combining the two sub-studies

PRIMARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies

The number of sperm per millimeter of semen. Sperm concentration is an important factor affecting male fertility. It is calculated on a standard semen analysis

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=32 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Sperm Concentration
Study A (men with normal sperm concentration)
53.6 million sperms/mL
Standard Deviation 36.4
58.5 million sperms/mL
Standard Deviation 32.8
Sperm Concentration
Study B (men with low sperm concentration)
20.1 million sperms/mL
Standard Deviation 59.16
15 million sperms/mL
Standard Deviation 16.8

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure total motility.

Total motility refers to the percentage of sperm making any sort of movement.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=29 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=33 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Total Motility
men with a normal sperm concentration
59.5 percentage of sperm that is motile
Standard Deviation 9.6
60.8 percentage of sperm that is motile
Standard Deviation 6.3
Total Motility
men with a low sperm concentration
48.9 percentage of sperm that is motile
Standard Deviation 12
45.4 percentage of sperm that is motile
Standard Deviation 16.1

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure progressive motility.

This type of motility refers to sperm that swim progressively, mostly in a straight line or large circles.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=29 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=33 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Progressive Motility
Study A (men with a normal sperm concentration)
53.3 percentage of progressively motile sperm
Standard Deviation 10.4
53.9 percentage of progressively motile sperm
Standard Deviation 6.1
Progressive Motility
study B (men with a low sperm concentration)
42.8 percentage of progressively motile sperm
Standard Deviation 14.1
39.6 percentage of progressively motile sperm
Standard Deviation 17

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure DNA fragmentation index.

Percentage of sperm with fragmented DNA

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=24 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=29 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
DNA Fragmentation Index (DFI)
Study A (men with a normal sperm concentration)
7.7 Percentage of sperm with fragmented DNA
Standard Deviation 8.7
19.8 Percentage of sperm with fragmented DNA
Standard Deviation 9.6
DNA Fragmentation Index (DFI)
study B (men with a low sperm concentration)
18.4 Percentage of sperm with fragmented DNA
Standard Deviation 11.7
11.2 Percentage of sperm with fragmented DNA
Standard Deviation 11

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. One participant in Low Energy Diet arm in study B did not have this measurement due to insufficient sample.

Testosterone is the primary androgen in men and is synthesized in the testes. It can be measured in the serum.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=31 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Testosterone
Study A (men with a normal sperm concentration)
13.6 nmol/l
Standard Deviation 5
12.4 nmol/l
Standard Deviation 2.8
Testosterone
study B (men with a low sperm concentration)
15.6 nmol/l
Standard Deviation 6.2
13.7 nmol/l
Standard Deviation 4.1

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. One participant in Low Energy Diet arm in study B did not have this measurement due to insufficient sample.

SHBG is a protein that is produced by the liver and binds tightly to the hormones testosterone, dihydrotestosterone (DHT) and oestradiol, and transports them in the blood in an inactive form.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=31 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Sex Hormone-Binding Globulin (SHBG)
(men with a normal sperm concentration)
30.2 nmol/l
Standard Deviation 12.6
26.4 nmol/l
Standard Deviation 7
Sex Hormone-Binding Globulin (SHBG)
study B (men with a low sperm concentration)
24.2 nmol/l
Standard Deviation 12.4
22.6 nmol/l
Standard Deviation 8.1

SECONDARY outcome

Timeframe: 16 weeks

Population: ROS was only measured in Study B. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure ROS.

ROS is measured by oxidative colour change of luminol per second per million sperm.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=14 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=19 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Reactive Oxygen Species (ROS)
13 RLU/sec/million sperm
Interval 3.0 to 39.1
5 RLU/sec/million sperm
Interval 0.9 to 37.4

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. Some participants in Study B were not assessed for this measure due to sperm concentrations that were too low to measure morphology.

the percentage of sperm that appear normal when semen is viewed under a microscope

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=27 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=31 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Morphology
Study A (men with a normal sperm concentration)
1.2 percentage of sperm of normal morphology
Standard Deviation 1.1
1.9 percentage of sperm of normal morphology
Standard Deviation 1.7
Morphology
Study B (men with a low sperm concentration)
0.6 percentage of sperm of normal morphology
Standard Deviation 0.6
1.3 percentage of sperm of normal morphology
Standard Deviation 1.7

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. One participant in Low Energy Diet arm in study B did not have this measurement due to insufficient sample.

LH produced in the pituitary gland, stimulates the leydig cells in the testes to produce testosterone.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=31 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Luteinizing Hormone (LH)
Study A (men with a normal sperm concentration)
3.3 IU/l
Standard Deviation 1.4
2.8 IU/l
Standard Deviation 1.2
Luteinizing Hormone (LH)
Study B (men with a low sperm concentration)
3.5 IU/l
Standard Deviation 1.4
3.7 IU/l
Standard Deviation 1.5

SECONDARY outcome

Timeframe: 16 weeks

Population: The overall number of participants analyzed refers to the total number after combining the two sub-studies. One participant in Low Energy Diet arm in study B did not have this measurement due to insufficient sample.

FSH produced in the pituitary gland, stimulates the testes to produce mature sperm.

Outcome measures

Outcome measures
Measure
Low Energy Diet
n=31 Participants
Commercially available diet products Low Energy Diet: Caloric restriction to achieve weight loss
NHS Advice on Healthy Eating
n=35 Participants
Dietary / lifestyle advice programme NHS advice on healthy eating: Advice on energy requirements as per the British Dietetic Association
Follicle Stimulating Hormone (FSH)
Study A (men with a normal sperm concentration)
3.8 IU/l
Standard Deviation 2.1
4.5 IU/l
Standard Deviation 2.2
Follicle Stimulating Hormone (FSH)
Study B (men with a low sperm concentration)
5.4 IU/l
Standard Deviation 2.6
5 IU/l
Standard Deviation 2.4

Adverse Events

Low Energy Diet

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

NHS Advice on Healthy Eating

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Channa Jayasena

Imperial College London

Phone: 02083833242

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place